Department of Error (DOI:10.1016/S0140-6736(08)61320-3);Retraction-autologous myoblasts and fibroblasts for treatment of stress urinary incontinence: a randomised controlled trial

The Lancet

Volumn 372, Issue 9641, 2008, Pages 789-790

  Kleinert, Sabine ^a   Horton, Richard ^a  

^a THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOTRANSPLANTATION; CLINICAL PRACTICE; FIBROBLAST; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MYOBLAST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRESS INCONTINENCE;

EID: 50649110295     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61552-4     Document Type: Erratum

References (4)

1. The editors of The Lancet. Expression of concern-autologous myoblasts and fibroblasts for treatment of stress urinary incontinence: a randomised controlled trial. Lancet 371 (2008) 1490
2. The Lancet, Department of Error, Strasser H., Marksteiner R., Margreiter E., et al. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial. Lancet 2007; 369: 2179-86. Lancet 371 (2008) 474
3. Strasser H., Marksteiner R., Margreiter E., et al. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial. Lancet 369 (2007) 2179-2186
4. Abbott A. Report finds grave flaws in urology trial. Nature (2008). http://www.nature.com/news/2008/080820/full/454922a.html;jsessionid=la9z7518uj2m 10.1038/454922a (accessed Sept 1, 2008).